<?xml version="1.0" encoding="UTF-8"?>
<fig id="F0002" orientation="portrait" position="float">
 <label>Figure 2.</label>
 <caption>
  <p>The antiviral activities are not subtype or cell line specific. A549, A431 cells or HUVECs were treated with either DMSO, posaconazole (Posa) or itraconazole (Itra) for 16 h, and subsequently infected with the indicated MOI of (A) IAV strain PR8M or (B) PAN for 24 h. (C) Postinfection treatment (2 h p.i.) of PR8M-infected A549 cells with either control, Itra or Posa. Data represent mean viral titers ± SEM, 
   <italic>n</italic> = 5; one-way ANOVA with Dunnett’s multiple comparison tests, ****
   <italic>p</italic> ≤ 0.0001;***
   <italic>p</italic> ≤ 0.001; **
   <italic>p</italic> ≤ 0.01; *
   <italic>p</italic> ≤ 0.05.
  </p>
 </caption>
 <alternatives>
  <graphic specific-use="web-only" content-type="black-white" xlink:href="TEMI_A_1559709_F0002_OB" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  <graphic specific-use="print-only" content-type="black-white" xlink:href="TEMI_A_1559709_F0002_PB" xmlns:xlink="http://www.w3.org/1999/xlink"/>
 </alternatives>
</fig>
